Improved clinical outcomes associated with the Impella 5.5 compared to the Impella 5.0 in contemporary cardiogenic shock and heart failure patients
Authors:
Open Access
- 1 February 2023
- journal article
- research article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 42 (5) , 553-557
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- A Case Series Analysis on the Clinical Experience of Impella 5.5® at a Large Tertiary Care CentreESC Heart Failure, 2021
- First in man evaluation of a novel circulatory support device: Early experience with the Impella 5.5 after CE mark approval in GermanyThe Journal of Heart and Lung Transplantation, 2021
- Early Outcomes of the First 200 US Patients Treated with Impella 5.5: A Novel Temporary Left Ventricular Assist DeviceInnovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, 2021